---
schema_version: "secwatch.filing_event.v1"
accession: "0001013762-23-006625"
form_type: "8-K"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2023-10-25T23:59:59+00:00"
generated_at: "2026-06-09T10:18:52.908421+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# OptimizeRx completes $95M acquisition of Medicx Health; appoints new President and CCO

## Summary
- Closed acquisition of Medicx Health for $95M in aggregate consideration (subject to adjustments).
- Management investors purchased ~$10.5M of OPRX common stock at $7.223/share as part of the deal.
- Steve Silvestro promoted to President, effective Oct 24; base salary increased to $400k.
- Theresa Greco (former Medicx President) named Chief Commercial Officer.
- Q3 2023 earnings call scheduled for Nov 6, 2023; financial results to be released prior.

## SEC filing metadata
- accession: 0001013762-23-006625
- form_type: 8-K
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2023-10-25T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.01, 9.01, 3.02, 5.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000101376223006625/0001013762-23-006625-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000101376223006625/ea187250-8k_optimizerx.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001013762-23-006625
- JSON: https://secwatch.observer/filing/0001013762-23-006625.json
- Plain text: https://secwatch.observer/filing/0001013762-23-006625.txt

## Key facts
- Executive change
  Stephen L. Silvestro was appointed as President at OptimizeRx Corp.
  - Action: appointed
  - Role: President
  source text: the Board determined to appoint Stephen L. Silvestro President of the Company effective as of the closing of the Merger.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1448431/000101376223006625/0001013762-23-006625-index.htm
- M&A Transactions
  OptimizeRx Corp completed an acquisition involving Healthy Offers, Inc. (d/b/a Medicx Health) for $95,000,000 (closed 2023-10-24).
  - Action: acquisition
  - Counterparty: Healthy Offers, Inc. (d/b/a Medicx Health)
  - Consideration: $95,000,000
  - Closing: 2023-10-24
  source text: company and a wholly-owned subsidiary of the Company (the “Merger”). The aggregate merger consideration the Company paid to the Securityholders of Medicx at the closing was $95,000,000, subject to certain customary post-acquisition purchase price adjustments. erger”). The aggregate merger consideration the Company paid to the Securityholders of Medicx at the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1448431/000101376223006625/0001013762-23-006625-index.htm
- Material Agreements
  OptimizeRx Corp entered into Subscription Agreement with Medicx Management Investors valued at 1,444,581 shares of common stock for $10.5 million (effective 2023-10-24).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Medicx Management Investors
  - Value: 1,444,581 shares of common stock for $10.5 million
  - Effective: 2023-10-24
  source text: On October 24, 2023, at the closing of the Merger, each Management Investor executed a common stock purchase agreement (the “Subscription Agreement”) to memorialize his or her purchase.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1448431/000101376223006625/0001013762-23-006625-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.